InsidersTradesSigma
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Thrive Partners VII Growth GP, LLC. Director active across 1 companies, notably Oscar Health, Inc.. Cumulatively, 14 reports have been published. Total volume traded: €40.4m. The latest transaction was disclosed on 9 September 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
€3m180,891 shares@ €14.571213.0% of flow
Class A Common Stock
SEC:0000899243-21-038101·
Ideal exit: 6 Jun 2022 (T+270)
€3m180,891 shares@ €14.57120.037% mcap6.5% of flow
Class A Common Stock
SEC:0000899243-21-038101:0·
Ideal exit: 6 Jun 2022 (T+270)
€8m515,344 shares@ €15.3339.1% of flow
Class A Common Stock
SEC:0000899243-21-036299·
Ideal exit: 11 Jun 2022 (T+270)
€8m515,344 shares@ €15.330.11% mcap19.5% of flow
Class A Common Stock
SEC:0000899243-21-036299:0·
Ideal exit: 11 Jun 2022 (T+270)
€3m180,891 shares@ €14.571213.0% of flow
Class A Common Stock
SEC:0000899243-21-035729·
Ideal exit: 6 Jun 2022 (T+270)
€3m180,891 shares@ €14.57120.037% mcap6.5% of flow
Class A Common Stock
SEC:0000899243-21-035729:0·
Ideal exit: 6 Jun 2022 (T+270)
€2m167,966 shares@ €14.757112.3% of flow
Class A Common Stock
SEC:0000899243-21-035248·
Ideal exit: 30 May 2022 (T+270)
€2m167,966 shares@ €14.75710.035% mcap6.1% of flow
Class A Common Stock
SEC:0000899243-21-035248:0·
Ideal exit: 30 May 2022 (T+270)
€3m274,697 shares@ €12.447716.9% of flow
Class A Common Stock
SEC:0000899243-21-034820·
Ideal exit: 27 May 2022 (T+270)
€3m274,697 shares@ €12.44770.049% mcap8.5% of flow
Class A Common Stock
SEC:0000899243-21-034820:0·
Ideal exit: 27 May 2022 (T+270)
€355,77931,794 shares@ €11.19011.8% of flow
Class A Common Stock
SEC:0000899243-21-034460·
Ideal exit: 22 May 2022 (T+270)
€355,77931,794 shares@ €11.19010.0051% mcap0.9% of flow
Class A Common Stock
SEC:0000899243-21-034460:0·
Ideal exit: 22 May 2022 (T+270)
€781,55768,042 shares@ €11.48643.9% of flow
Class A Common Stock
SEC:0000899243-21-034081·
Ideal exit: 17 May 2022 (T+270)
€781,55768,042 shares@ €11.48640.011% mcap1.9% of flow
Class A Common Stock
SEC:0000899243-21-034081:0·
Ideal exit: 17 May 2022 (T+270)
14 of 14 declarations
About Thrive Partners VII Growth GP, LLC
Thrive Partners VII Growth GP, LLC is a director and insider at Oscar Health, Inc.
